Kodiak Sciences (KOD) Amortization of Deferred Charges (2017 - 2026)

Kodiak Sciences (KOD) posted Amortization of Deferred Charges of $2.2 million for Q1 2026, up 13.19% on a QoQ basis from $2.0 million in Q4 2025, and up 4.99% year-over-year from $2.1 million in Q1 2025.

Kodiak Sciences (KOD) Amortization of Deferred Charges (2017 - 2026) Analysis & Trends

Kodiak Sciences' Amortization of Deferred Charges history runs 9 years deep, the most recent figure standing at $2.2 million for Q1 2026.

  • Quarterly Amortization of Deferred Charges rose 4.99% year-over-year to $2.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.1 million (down 0.98% YoY) and the FY2025 annual result came in at $8.0 million, changed 0.05% from the prior year.
  • Amortization of Deferred Charges was $2.2 million for Q1 2026 at Kodiak Sciences, up from $2.0 million in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $2.2 million in Q1 2026 and bottomed at $1.7 million in Q3 2022.
  • A 5-year average of $1.9 million and a median of $1.9 million in 2025 frame the typical range for Amortization of Deferred Charges.
  • Annual changes were most pronounced in 2022 — Amortization of Deferred Charges dropped 10.34% — and 2023, when it gained 14.57%.
  • Kodiak Sciences' Amortization of Deferred Charges stood at $1.7 million in 2022, then advanced by 10.93% to $1.9 million in 2023, then climbed by 6.09% to $2.1 million in 2024, then decreased by 4.13% to $2.0 million in 2025, then grew by 13.19% to $2.2 million in 2026.
  • Business Quant data shows KOD's Amortization of Deferred Charges at $2.2 million in Q1 2026, $2.0 million in Q4 2025, and $2.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,681.27 Bn 66,680.98 Bn -
2 Nanobiotix 1,911.83 Bn 1,911.77 Bn -
3 Akari Therapeutics 959.56 Bn 959.56 Bn -
4 BeOne Medicines 472.75 Bn 467.96 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.14 Bn 114.89 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.09 Bn 61.34 Bn 3.31 Bn
7 Belite Bio 62.34 Bn 62.34 Bn -
8 Argenx Se 55.94 Bn 50.76 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.52 Bn 34.51 Bn 959.66 Mn
10 Kodiak Sciences 2.62 Bn 2.62 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 2.23 Mn
Mar 31, 2026 2.23 Mn
Dec 31, 2025 1.97 Mn
Dec 31, 2025 1.97 Mn
Sep 30, 2025 1.95 Mn
Sep 30, 2025 1.95 Mn
Jun 30, 2025 1.94 Mn
Jun 30, 2025 1.94 Mn
Mar 31, 2025 2.13 Mn
Mar 31, 2025 2.13 Mn
Dec 31, 2024 2.06 Mn
Dec 31, 2024 2.06 Mn
Sep 30, 2024 2.01 Mn
Sep 30, 2024 2.01 Mn
Jun 30, 2024 1.99 Mn
Jun 30, 2024 1.99 Mn
Mar 31, 2024 1.94 Mn
Mar 31, 2024 1.94 Mn
Dec 31, 2023 1.94 Mn
Dec 31, 2023 1.94 Mn